Adult onset moyamoya disease: institutional experience

Swati Dayanand Chinchure1, Hima Shriniwas Pendharkar, Arun Kumar Gupta

  • 1Department of Imaging Sciences and Interventional Radiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India.

Neurology India
|October 25, 2011
PubMed

Insights

Adult-onset moyamoya disease, a rare condition affecting brain arteries, can cause serious bleeding or stroke. This study highlights its importance in diagnosing adult intracranial hemorrhage.

Area of Science:

  • Neurology
  • Vascular Neurology
  • Neuroimaging

Background:

  • Moyamoya disease is a rare, progressive steno-occlusive condition affecting the major arteries at the base of the brain.
  • It is characterized by the formation of a delicate collateral vascular network, diagnosed via angiography.
  • Adult-onset moyamoya disease presents unique diagnostic challenges.

Observation:

  • This study analyzed 11 patients diagnosed with adult-onset moyamoya disease.
  • The primary clinical presentations were intracranial hemorrhage (6 patients) and focal ischemia (5 patients).
  • Angiographic findings included bilateral internal carotid artery involvement (8 patients) and unilateral involvement (3 patients), with posterior cerebral artery involvement in 3 patients.

Findings:

  • Adult-onset moyamoya disease can manifest as severe neurological events like intracerebral and intraventricular hemorrhage.
  • The disease predominantly affects the internal carotid arteries, but posterior circulation can also be involved.
  • Aneurysms are an uncommon but possible associated finding.

Implications:

  • Adult-onset moyamoya disease should be considered in the differential diagnosis of spontaneous intracranial hemorrhage in adults.
  • Early recognition and diagnosis are crucial for appropriate management and to prevent further neurological damage.
  • Further research into the specific mechanisms and optimal treatment strategies for adult-onset moyamoya disease is warranted.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...